AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

NIH-funded HIV vaccine design and development team in place.

Vaccine Weekly

| November 19, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 NOV 19 - (NewsRx.com & NewsRx.net) -- The U.S. National Institutes of Health (NIH) has awarded a $19 million, 5-year grant for HIV vaccine development grant to Novavax, Inc., along with partners at Emory University School of Medicine and the Emory Vaccine Center, Tulane University, and the University of Pittsburgh.

The award is part of the National Institute of Allergy and Infectious Disease (NIAID) Vaccine Design and Development Teams program. The Emory team of researchers includes Richard W. Compans, PhD, professor and chair of microbiology and immunology and faculty members Sang-Moo Kang, PhD, Andrei N. Vzorov, PhD, and Chinglai Yang, PhD.

Scientists at Emory and Novavax, Inc., including Robin A. Robinson, PhD, director of Novavax's vaccine division and principal investigator for the grant, are developing and testing a novel virus-like particle (VLP) vaccine. The genes that encode the main structural proteins of HIV (the envelope and gag core proteins) will first be expressed in insect or mammalian cells. These proteins self-assemble to form VLPs, which are devoid of the virus genes themselves, and will be purified to form the vaccine. The investigators propose to deliver this protein-based vaccine in a manner that they predict will induce broad neutralizing antibodies against HIV in blood and mucosal tissues. The HIV genes for initial testing of the vaccine were taken from HIV strains in circulation in the United States. In subsequent studies the investigators will use genes from other geographic ...

Related articles from newspapers, magazines, journals, and more
Enhancement of mucosal immune responses by chimeric influenza HA/SHIV...
Magazine article from: Research Initiative/Treatment Action! Yao, Qizhi March 22, 2003 700+ words
...To enhance mucosal immune responses using simian-human...humoral and cellular immune responses at multiple mucosal...Summary Cathy Yao, MD, PhD, began her presentation...humoral and cellular immune responses, and they can be administered...
New data on Remune suggests HIV-1 specific immune responses.
Newspaper article from: Drug Week July 9, 2004 700+ words
...HIV-1 specific immune responses in a number of...HIV-1 specific immune responses is thought to be...N. Bonfiglio, PhD, chief executive...Georgia Theofan, PhD, vice president...HIV-specific immune responses, including gamma...
Studies Show TIM-3 Proteins Play Role in Immune Responses.(T cell...
News wire article from: AScribe Medicine News Service October 30, 2003 700+ words
...to inhibit aggressive immune responses could have important...Vijay Kuchroo, DVM, PhD, found, for the first...ongoing TH1-dependent immune responses," explains Strom...Carlos Gutierrez-Ramos, PhD, and Anthony Coyle...
Boosting Newborns' Immune Responses; Researchers Identify Agents That May Make...
News wire article from: Ascribe Higher Education News Service April 24, 2006 700+ words
...Blood on April 25, Ofer Levy, MD, PhD and colleagues in Children's Division...receptors are stimulated, newborns' immune responses are very impaired," Levy says...stimulate TLR8 could be used to enhance immune responses in newborns, perhaps as adjuvants given...
New Research on Gene Therapy Clinical Trials, Today's Findings From the ASGT...
Press release article from: PR Newswire June 3, 2004 700+ words
...the American Society of Gene Therapy (ASGT). Boro Dorpulic, PhD, Johns Hopkins School of Medicine, and colleagues removed the...Adenosine Deaminase (ADA) deficiency. Alessandro Aiuti, MD, PhD, San Raffaele Telethon Institute for Gene Therapy, Italy...
Scientists discover how to grow cells that suppress immune responses.
Newspaper article from: Biotech Week February 12, 2003 700+ words
...cells from that sample and a few days later have a nice population of T-regulatory cells," said first author Claudia Kemper, PhD, a postdoctoral fellow in Atkinson's laboratory. "To be able to manipulate the activity of Tr1 cells for future therapeutic...
Breast cancer risk and immune responses in healthy women.(Clinical report)
Magazine article from: Oncology Nursing Forum Park, Na-Jin Kang, Duck-Hee November 1, 2006 700+ words
...association with psychological distress and immune responses in healthy women with a family history...breast cancer have shown decreased immune responses (i.e., low natural killer cell...cancer risk is associated with impaired immune responses and exaggerated biophysiologic ...
Plasma pyridoxal 5'-phosphate is a significant indicator of immune responses in...
Magazine article from: Alternative Medicine Review Huang, Y.C. Chang, H.H. Huang, S.C. September 1, 2005 700+ words
...phosphate is a significant indicator of immune responses in the mechanically ventilated critically...the effect of vitamin B6 status on immune responses in mechanically ventilated, critically...sensitivity C-reactive protein, and immune responses (white blood cell, neutrophil...
For more facts and information, see all results

Source: HighBeam Research, NIH-funded HIV vaccine design and development team in place.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA